Skip to content
value.today

Vertos Medical Inc.

Total raised
$177 M
11 rounds on record
Latest round
$45 M
May 2023
First round on record
Oct 2009
Today
Private
No later event on record

Funding rounds

11 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Vertos Medical Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2023$45 MNo. 11$10 to $50 million

Vertos Medical Inc.: Raise no. 11, May 2023

Investors in this round

29 investors had bought by the notice of Jun 6, 2023: 29 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$45 M of $46 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Eric Wichems · Executive Officer, Director
  • Rebecca Colbert · Executive Officer
  • Daniel Pelak · Director
  • Hugo Harrod · Director
  • Ittai Harel · Director
  • Mike Boggs · Director
  • Zachary Scott · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Total amount sold includes $24,999,998.89 new money; $19,557,632.09 conversion of notes.”

Signed by Eric Wichems, Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 6, 2023. Read the notice at the SEC.

equitySEC
May 2021$17 MNo. 10$10 to $50 million

Vertos Medical Inc.: Raise no. 10, May 2021

Investors in this round

23 investors had bought by the notice of Nov 18, 2021: 23 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$17 M of $17 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bruce Feuchter · Executive Officer
  • Eric Wichems · Executive Officer, Director
  • Rebecca Colbert · Executive Officer
  • Daniel Pelak · Director
  • Hugo Harrod · Director
  • Ittai Harel · Director
  • Robert Kuhling · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Subordinated Convertible Promissory Notes”

Signed by Bruce Feuchter, Secretary. Source: SEC Form D, newest notice filed Nov 18, 2021. Read the notice at the SEC.

debt, optionsSEC
Sep 2019$26 MNo. 9$10 to $50 million

Vertos Medical Inc.: Raise no. 9, Sep 2019

Investors in this round

13 investors had bought by the notice of Sep 30, 2019: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$26 M of $28 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bruce Feuchter · Executive Officer
  • Eric Wichems · Executive Officer, Director
  • Rebecca Colbert · Executive Officer
  • Daniel Pelak · Director
  • Hugo Harrod · Director
  • Ittai Harel · Director
  • Robert Kuhling · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Series B Preferred Stock and Warrants”

Signed by Bruce Feuchter, Secretary. Source: SEC Form D, newest notice filed Sep 30, 2019. Read the notice at the SEC.

equity, optionsSEC
Jun 2017$29 MNo. 8$10 to $50 million

Vertos Medical Inc.: Raise no. 8, Jun 2017

Investors in this round

21 investors had bought by the notice of Jun 19, 2017: 21 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$29 M of $29 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bruce Feuchter · Executive Officer
  • Eric Wichems · Executive Officer, Director
  • Rebecca Colbert · Executive Officer
  • Daniel Pelak · Director
  • Ittai Harel · Director
  • John Ryan · Director
  • Michael Boggs · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Series B Preferred Stock and conversion of indebtedness”

Signed by Bruce Feuchter, Secretary. Source: SEC Form D, newest notice filed Jun 19, 2017. Read the notice at the SEC.

equitySEC
Dec 2014$6 MNo. 7$2 to $10 million

Vertos Medical Inc.: Raise no. 7, Dec 2014

Investors in this round

21 investors had bought by the notice of May 12, 2015: 21 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $12 M offered; $6 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bruce Feuchter · Executive Officer
  • Eric Wichems · Executive Officer, Director
  • Rebecca Colbert · Executive Officer
  • Daniel Pelak · Director
  • Ittai Harel · Director
  • John Ryan · Director
  • Myles Greenberg · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Series 1 & Series 2 Preferred Stock”

Signed by Bruce Feuchter, Secretary. Source: SEC Form D, newest notice filed May 12, 2015. Read the notice at the SEC.

equitySEC
Jun 2013$23 MNo. 6$10 to $50 million

Vertos Medical Inc.: Raise no. 6, Jun 2013

Investors in this round

63 investors had bought by the notice of Jun 28, 2013: 63 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$23 M of $23 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bruce F. Feuchter · Executive Officer
  • James M. Corbett · Executive Officer, Director
  • Rebecca F. Colbert · Executive Officer
  • Andrew M. Firlik · Director
  • Daniel F. Pelak · Director
  • John F. Ryan · Director
  • Myles M. Greenberg · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Bruce Feuchter, Secretary. Source: SEC Form D, newest notice filed Jun 28, 2013. Read the notice at the SEC.

equitySEC
Apr 2013$2 MNo. 5Under $2 million

Vertos Medical Inc.: Raise no. 5, Apr 2013

Investors in this round

8 investors had bought by the notice of May 2, 2013: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bruce M. Feuchter · Executive Officer
  • James M. Corbett · Executive Officer, Director
  • Rebecca M. Colbert · Executive Officer
  • Andrew M. Firlik · Director
  • Daniel M. Pelak · Director
  • Daniel M. Watkins · Director
  • John F. Ryan · Director
  • Myles M. Greenberg · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Sale and issuance of Convertible Promissory Notes”

Signed by Bruce Feuchter, Secretary. Source: SEC Form D, newest notice filed May 2, 2013. Read the notice at the SEC.

debt, optionsSEC
Dec 2012$2 MNo. 4$2 to $10 million

Vertos Medical Inc.: Raise no. 4, Dec 2012

Investors in this round

10 investors had bought by the notice of Dec 27, 2012: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bruce M. Feuchter · Executive Officer
  • James M. Corbett · Executive Officer, Director
  • Rebecca M. Colbert · Executive Officer
  • Andrew M. Firlik · Director
  • Daniel M. Pelak · Director
  • Daniel M. Watkins · Director
  • John M. Ryan · Director
  • Myles M. Greenberg · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Bruce Feuchter, Secretary. Source: SEC Form D, newest notice filed Dec 27, 2012. Read the notice at the SEC.

debt, optionsSEC
Apr 2012$5 MNo. 3$2 to $10 million

Vertos Medical Inc.: Raise no. 3, Apr 2012

Investors in this round

6 investors had bought by the notice of May 7, 2012: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bruce Feuchter · Executive Officer
  • James Corbett · Executive Officer, Director
  • Rebecca Colbert · Executive Officer
  • Andrew Firlik · Director
  • Daniel Pelak · Director
  • Daniel Watkins · Director
  • John Ryan · Director
  • Myles Greenberg · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Sales of Subordinated Convertible Promissory Notes”

Signed by Bruce Feuchter, Secretary. Source: SEC Form D, newest notice filed May 7, 2012. Read the notice at the SEC.

debt, optionsSEC
May 2011$8 MNo. 2$2 to $10 million

Vertos Medical Inc.: Raise no. 2, May 2011

Investors in this round

7 investors had bought by the notice of May 20, 2011: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $8 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bruce Feuchter · Executive Officer
  • James Corbett · Executive Officer, Director
  • Andrew Firlik · Director
  • Daniel Pelak · Director
  • Daniel Watkins · Director
  • John Ryan · Director
  • Myles Greenberg · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Series D-1 Preferred Stock”

Signed by Bruce Feuchter, Secretary. Source: SEC Form D, newest notice filed May 20, 2011. Read the notice at the SEC.

equitySEC
Oct 2009$15 MNo. 1$10 to $50 million

Vertos Medical Inc.: Raise no. 1, Oct 2009

Investors in this round

28 investors had bought by the notice of Oct 27, 2009: 28 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $15 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bruce M. Feuchter · Executive Officer
  • James M Corbett · Executive Officer, Director
  • Andrew M Firlik · Director
  • Daniel M. Pelak · Director
  • Daniel M. Watkins · Director
  • Harry M Ross · Director
  • John M. Ryan · Director
  • Myles M Greenberg · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Bruce Feuchter, Secretary. Source: SEC Form D, newest notice filed Oct 27, 2009. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Vertos Medical Inc. chose not to state its revenue in its newest notice of a funding round (Jun 2023).

    SEC Form D · Jun 2023

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jun 2023

That is all the official record says: Vertos Medical Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Vertos Medical Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 11 rounds above had up to 63 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Vertos Medical Inc.
NameRoleNamed in
Eric WichemsExecutive officerJun 2023
Rebecca ColbertExecutive officerJun 2023
Bruce FeuchterExecutive officerNov 2021
Bruce F. FeuchterExecutive officerJun 2013
James M. CorbettExecutive officerJun 2013
Rebecca F. ColbertExecutive officerJun 2013
Bruce M. FeuchterExecutive officerMay 2013
Rebecca M. ColbertExecutive officerMay 2013
James CorbettExecutive officerMay 2012
James M CorbettExecutive officerOct 2009
Daniel PelakDirectorJun 2023
Eric WichemsDirectorJun 2023
Hugo HarrodDirectorJun 2023
Ittai HarelDirectorJun 2023
Mike BoggsDirectorJun 2023
Zachary ScottDirectorJun 2023
Robert KuhlingDirectorNov 2021
John RyanDirectorJun 2017
Michael BoggsDirectorJun 2017
Myles GreenbergDirectorMay 2015
Andrew M. FirlikDirectorJun 2013
Daniel F. PelakDirectorJun 2013
James M. CorbettDirectorJun 2013
John F. RyanDirectorJun 2013
Myles M. GreenbergDirectorJun 2013
Daniel M. PelakDirectorMay 2013
Daniel M. WatkinsDirectorMay 2013
John M. RyanDirectorDec 2012
Andrew FirlikDirectorMay 2012
Daniel WatkinsDirectorMay 2012
James CorbettDirectorMay 2012
Andrew M FirlikDirectorOct 2009
Harry M RossDirectorOct 2009
James M CorbettDirectorOct 2009
Myles M GreenbergDirectorOct 2009